Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 6581 results found since Jan 2013.

Eliminating Potential Effects of Other Infections during Selection of Nonhuman Primates for COVID-19 Research
Comp Med. 2023 Jan 4;73(1):45-57. doi: 10.30802/AALAS-CM-21-000086. Online ahead of print.ABSTRACTThe study of nonhuman primates (NHP) can provide significant insights into our understanding numerous infectious agents. The etiological agent of COVID-19, SARS-CoV-2 virus, first emerged in 2019 and has so far been responsible for the deaths of over 4 million people globally. In the frenzied search to understand its pathogenesis and immunology and to find measures for prevention and control of this pandemic disease, NHP, particularly macaques, are the preferred model because they manifest similar clinical signs and immunologi...
Source: Comparative Medicine - February 6, 2023 Category: Zoology Authors: M árcia Cr Andrade B árbara Rp Lemos Larissa M Silva Jerilyn K Pecotte Source Type: research

Eliminating Potential Effects of Other Infections During Selection of Nonhuman Primates for COVID-19 Research
Comp Med. 2023 Feb 1;73(1):45-57. doi: 10.30802/AALAS-CM-21-000086. Epub 2023 Jan 4.ABSTRACTThe study of nonhuman primates (NHP) can provide significant insights into our understanding numerous infectious agents. The etiological agent of COVID-19, SARS-CoV-2 virus, first emerged in 2019 and has so far been responsible for the deaths of over 4 million people globally. In the frenzied search to understand its pathogenesis and immunology and to find measures for prevention and control of this pandemic disease, NHP, particularly macaques, are the preferred model because they manifest similar clinical signs and immunologic feat...
Source: Comparative Medicine - February 6, 2023 Category: Zoology Authors: Marcia C R Andrade B árbara R P Lemos Larissa M Silva Jerilyn K Pecotte Source Type: research

Exclusion of older adults and immunocompromised  individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
CONCLUSIONS: During the COVID-19 pandemic, we found a decrease in the exclusion of older adults from vaccine trials but no significant change in the inclusion of immunocompromised individulas.PMID:37027085 | PMC:PMC10080508 | DOI:10.1007/s40520-023-02380-4
Source: Aging Clinical and Experimental Research - April 7, 2023 Category: Geriatrics Authors: Katrine Bukan Toby Pearce-Slade Mads Eiberg Marco Tinelli Dafna Yahav Jose Tuells Olivier Epaulard Jon G Holler Casper Roed Christian S øborg Jens-Ulrik St æhr Jensen Zitta Barrella Harboe Source Type: research

Public perception of COVID-19 vaccines through analysis of Twitter content and users
This study successfully explores sentiment, emotion, topics, and user demographics to elucidate important trends in public perception about COVID-19 vaccines. While public perception trended positively over the study period, some trends, especially within certain topic and demographic clusters, are concerning for COVID-19 vaccine hesitancy. These insights can provide targets for educational interventions and opportunity for continued real-time monitoring.PMID:37385887 | PMC:PMC10288320 | DOI:10.1016/j.vaccine.2023.06.058
Source: Vaccine - June 29, 2023 Category: Allergy & Immunology Authors: Sameh N Saleh Samuel A McDonald Mujeeb A Basit Sanat Kumar Reuben J Arasaratnam Trish M Perl Christoph U Lehmann Richard J Medford Source Type: research

Pneumococcal conjugate vaccines for preventing otitis media.
CONCLUSIONS: Based on current evidence of the effects of PCVs for preventing AOM, the licensed 7-valent CRM197-PCV7 has modest beneficial effects in healthy infants with a low baseline risk of AOM. Administering PCV7 in high-risk infants, after early infancy and in older children with a history of AOM, appears to have no benefit in preventing further episodes. Currently, several RCTs with different (newly licensed, multivalent) PCVs administered during early infancy are ongoing to establish their effects on AOM. Results of these studies may provide a better understanding of the role of the newly licensed, multivalent PCVs ...
Source: Cochrane Database of Systematic Reviews - April 2, 2014 Category: Journals (General) Authors: Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA Tags: Cochrane Database Syst Rev Source Type: research

Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke
Conclusions: Influenza vaccination was not associated with reduced outcome events in patients with recent atherothrombotic ischemic stroke after considering all baseline characteristics (including concomitant medications) associated with influenza vaccination.
Source: Neurology - May 26, 2014 Category: Neurology Authors: Lavallee, P. C., Labreuche, J., Fox, K. M., Lavados, P., Mattle, H., Steg, P. G., Amarenco, P., On behalf of the PERFORM, OPTIC, and AMISTAD Investigators Tags: Stroke prevention, Viral infections, All Cerebrovascular disease/Stroke ARTICLE Source Type: research

Recurrent Encephalitis after Seasonal Influenza Vaccine (P5.100)
Conclusions: We highlight the potential association between the influenza vaccine and acute reactive encephalitis in this patient. Albeit unusual, recurrence supports this postulation.Disclosure: Dr. Narwal has nothing to disclose. Dr. Daniel has nothing to disclose. Dr. Mintz has nothing to disclose. Dr. Nouh has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Narwal, P., Daniel, A., Mintz, C., Nouh, A. Tags: Edema, Encephalopathy, and Encephalitis Source Type: research

Strategies for addressing vaccine hesitancy - A systematic review.
Abstract The purpose of this systematic review is to identify, describe and assess the potential effectiveness of strategies to respond to issues of vaccine hesitancy that have been implemented and evaluated across diverse global contexts. METHODS: A systematic review of peer reviewed (January 2007-October 2013) and grey literature (up to October 2013) was conducted using a broad search strategy, built to capture multiple dimensions of public trust, confidence and hesitancy concerning vaccines. This search strategy was applied and adapted across several databases and organizational websites. Descriptive analy...
Source: Vaccine - April 17, 2015 Category: Allergy & Immunology Authors: Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ, SAGE Working Group on Vaccine Hesitancy Tags: Vaccine Source Type: research